{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:03:20Z","timestamp":1776866600285,"version":"3.51.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:p>Three cases of optic disc edema arising from radiation optic neuropathy isolated to the intra-ocular optic nerve following external beam radiation for head and neck squamous cell carcinoma are presented. A literature review of the etiology, presentation, and treatment is included for discussion, along with proposed diagnostic criteria.<\/jats:p>","DOI":"10.3389\/fopht.2023.1144241","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T05:09:33Z","timestamp":1682658573000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Successful treatment of external beam radiation-induced optic papillopathy with intravitreal anti-VEGF"],"prefix":"10.3389","volume":"3","author":[{"given":"Andrew R.","family":"Carey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"bjo-2022-322854","DOI":"10.1136\/bjo-2022-322854","article-title":"Radiation-induced optic neuropathy: a review","volume":"23","author":"Carey","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2020.08.007","article-title":"Treatment of radiation maculopathy and radiation-induced macular edema: a systematic review","volume":"66","author":"Fallico","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.07.004","article-title":"Radiation-induced optic neuropathy: observation versus intravitreal treatment: can visual acuity be maintained by intravitreal treatment","volume":"208","author":"Eckstein","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3171\/2014.9.PEDS14198","article-title":"Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain","volume":"15","author":"Dashti","year":"2015","journal-title":"J Neurosurg Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.04.068","article-title":"Bevacizumab monotherapy reduces radiation-induced brain necrosis in nasopharyngeal carcinoma patients: a randomized controlled trial","volume":"101","author":"Xu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npv064","article-title":"A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis\u2020","volume":"3","author":"Furuse","year":"2016","journal-title":"Neurooncol Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02200-5","article-title":"Early anti-VEGF treatment for radiation maculopathy and optic neuropathy: lessons learned","volume":"37","author":"Powell","year":"2022","journal-title":"Eye (Lond)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","year":"2012","journal-title":"Ophthalmology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.09.018","article-title":"Ranibizumab or bevacizumab for neovascular age-related macular degeneration according to the lucentis compared to avastin study treat-and-Extend protocol: two-year results","volume":"123","author":"Berg","year":"2016","journal-title":"Ophthalmology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200605000-00007","article-title":"Intravitreal triamcinolone acetonide for acute radiation papillopathy","volume":"26","author":"Shields","year":"2006","journal-title":"Retina"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.11.075","article-title":"Antivascular endothelial growth factor bevacizumab for radiation optic neuropathy: secondary to plaque radiotherapy","volume":"82","author":"Finger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000487543","article-title":"The use of intravitreal anti-VEGF and triamcinolone in the treatment of radiation papillopathy","volume":"4","author":"Roelofs","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S23650","article-title":"Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer","volume":"5","author":"Gondo","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.05.003","article-title":"Immune checkpoint inhibitor-associated optic neuritis","volume":"127","author":"Francis","year":"2020","journal-title":"Ophthalmology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2147\/EB.S277760","article-title":"Neuro-ophthalmic complications of immune checkpoint inhibitors: a systematic review","volume":"12","author":"Yu","year":"2020","journal-title":"Eye Brain"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.2100","article-title":"Radiation induced CNS toxicity\u2013molecular and cellular mechanisms","volume":"85","author":"Belka","year":"2001","journal-title":"Br J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13797","article-title":"Retinal perfusion changes in radiation retinopathy","volume":"96","author":"Rose","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(82)34611-4","article-title":"Radiation retinopathy","volume":"89","author":"Brown","year":"1982","journal-title":"Ophthalmology"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2023.1144241\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T05:09:36Z","timestamp":1682658576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2023.1144241\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":19,"alternative-id":["10.3389\/fopht.2023.1144241"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2023.1144241","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"article-number":"1144241"}}